Eli Lilly (LLY) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
-36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.04% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
31.95% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.77% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-25.38% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
73.24% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
12.50% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-22.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
33.46% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
54.04% |
| Dec 31, 2025 |
70.21% |
| Sep 30, 2025 |
54.56% |
| Jun 30, 2025 |
38.52% |
| Mar 31, 2025 |
53.10% |
| Dec 31, 2024 |
39.70% |
| Sep 30, 2024 |
39.20% |
| Jun 30, 2024 |
65.92% |
| Mar 31, 2024 |
47.54% |
| Dec 31, 2023 |
113.90% |
| Sep 30, 2023 |
57.21% |
| Jun 30, 2023 |
98.98% |
| Mar 31, 2023 |
82.95% |
| Dec 31, 2022 |
71.83% |
| Sep 30, 2022 |
83.25% |
| Jun 30, 2022 |
-2.70% |
| Mar 31, 2022 |
21.68% |
| Dec 31, 2021 |
-35.91% |
| Sep 30, 2021 |
-14.32% |
| Jun 30, 2021 |
35.31% |
| Mar 31, 2021 |
16.26% |
| Dec 31, 2020 |
39.26% |
| Sep 30, 2020 |
49.24% |
| Jun 30, 2020 |
17.27% |
| Mar 31, 2020 |
26.80% |
| Dec 31, 2019 |
-17.20% |
| Sep 30, 2019 |
-2.37% |
| Jun 30, 2019 |
-22.48% |
| Mar 31, 2019 |
-13.87% |
| Dec 31, 2018 |
-11.09% |
| Sep 30, 2018 |
11.17% |
| Jun 30, 2018 |
39.89% |
| Mar 31, 2018 |
39.94% |
| Dec 31, 2017 |
8.22% |
| Sep 30, 2017 |
6.68% |
| Jun 30, 2017 |
-9.70% |
| Mar 31, 2017 |
9.53% |
| Dec 31, 2016 |
7.79% |
| Sep 30, 2016 |
-16.82% |
| Jun 30, 2016 |
9.60% |
| Mar 31, 2016 |
-18.19% |
| Dec 31, 2015 |
-7.00% |
| Sep 30, 2015 |
-7.88% |
| Jun 30, 2015 |
-12.16% |
| Mar 31, 2015 |
-6.63% |
| Dec 31, 2014 |
-11.90% |
| Sep 30, 2014 |
16.98% |
| Jun 30, 2014 |
86.88% |
| Mar 31, 2014 |
27.93% |
| Dec 31, 2013 |
12.29% |
| Sep 30, 2013 |
39.45% |
| Jun 30, 2013 |
-24.01% |
| Mar 31, 2013 |
20.81% |
| Dec 31, 2012 |
61.47% |
| Sep 30, 2012 |
3.59% |
| Jun 30, 2012 |
29.14% |
| Mar 31, 2012 |
28.90% |
| Dec 31, 2011 |
1.99% |
| Sep 30, 2011 |
7.07% |
| Jun 30, 2011 |
-9.86% |
| Mar 31, 2011 |
-18.94% |
| Dec 31, 2010 |
-2.30% |
| Sep 30, 2010 |
-5.85% |
| Jun 30, 2010 |
-12.83% |
| Mar 31, 2010 |
-20.32% |
